Zymeworks, Inc. is a global biotechnology company focusing on the discovery, development, and commercialisation of next-generation multifunctional therapies. These therapies are created for prevalent and life-threatening diseases including cancer.
Operating in the biotechnology industry, Zymeworks engineers and develops antibody-based therapeutic treatments. The company’s novel therapies are marked by its proprietary complementary therapeutic platforms. Zymeworks has partnerships with multiple companies including BeiGene, ALX Oncology, LEO Pharma, and more.
Keep up to date on the latest share price changes by adding ZYME stock to your eToro watchlist.